These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21102443)

  • 1. Transcriptional regulation of BRCA1 expression by a metabolic switch.
    Di LJ; Fernandez AG; De Siervi A; Longo DL; Gardner K
    Nat Struct Mol Biol; 2010 Dec; 17(12):1406-13. PubMed ID: 21102443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cooperation between BRCA1 and vitamin D is critical for histone acetylation of the p21waf1 promoter and growth inhibition of breast cancer cells and cancer stem-like cells.
    Pickholtz I; Saadyan S; Keshet GI; Wang VS; Cohen R; Bouwman P; Jonkers J; Byers SW; Papa MZ; Yarden RI
    Oncotarget; 2014 Dec; 5(23):11827-46. PubMed ID: 25460500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic interactions between the promoter and terminator regions of the mammalian BRCA1 gene.
    Tan-Wong SM; French JD; Proudfoot NJ; Brown MA
    Proc Natl Acad Sci U S A; 2008 Apr; 105(13):5160-5. PubMed ID: 18375767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Egr-1 regulates the transcription of the BRCA1 gene by etoposide.
    Shin SY; Kim CG; Lee YH
    BMB Rep; 2013 Feb; 46(2):92-6. PubMed ID: 23433111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiling of the BRCA1 transcriptome through microarray and ChIP-chip analysis.
    Gorski JJ; Savage KI; Mulligan JM; McDade SS; Blayney JK; Ge Z; Harkin DP
    Nucleic Acids Res; 2011 Dec; 39(22):9536-48. PubMed ID: 21880590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide profiles of CtBP link metabolism with genome stability and epithelial reprogramming in breast cancer.
    Di LJ; Byun JS; Wong MM; Wakano C; Taylor T; Bilke S; Baek S; Hunter K; Yang H; Lee M; Zvosec C; Khramtsova G; Cheng F; Perou CM; Miller CR; Raab R; Olopade OI; Gardner K
    Nat Commun; 2013; 4():1449. PubMed ID: 23385593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CtBP maintains cancer cell growth and metabolic homeostasis via regulating SIRT4.
    Wang L; Zhou H; Wang Y; Cui G; Di LJ
    Cell Death Dis; 2015 Jan; 6(1):e1620. PubMed ID: 25633289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic modulation of CtBP dimeric status impacts the repression of DNA damage repair genes and the platinum sensitivity of ovarian cancer.
    Li J; Wang Y; Wang L; Hao D; Li P; Su M; Zhao Z; Liu T; Tai L; Lu J; Di LJ
    Int J Biol Sci; 2023; 19(7):2081-2096. PubMed ID: 37151877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Breast Cancer Protooncogenes HER2, BRCA1 and BRCA2 and Their Regulation by the iNOS/NOS2 Axis.
    Lin K; Baritaki S; Vivarelli S; Falzone L; Scalisi A; Libra M; Bonavida B
    Antioxidants (Basel); 2022 Jun; 11(6):. PubMed ID: 35740092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Difluoromethylornithine (DFMO) Enhances the Cytotoxicity of PARP Inhibition in Ovarian Cancer Cells.
    El Naggar O; Doyle B; Mariner K; Gilmour SK
    Med Sci (Basel); 2022 May; 10(2):. PubMed ID: 35736348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Histone Modifications in Breast Cancer: A Precise Weapon on the Way.
    Li W; Wu H; Sui S; Wang Q; Xu S; Pang D
    Front Cell Dev Biol; 2021; 9():736935. PubMed ID: 34595180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRCA1 Antibodies Matter.
    Yang J; Qi L; Chiang HC; Yuan B; Li R; Hu Y
    Int J Biol Sci; 2021; 17(12):3239-3254. PubMed ID: 34421362
    [No Abstract]   [Full Text] [Related]  

  • 13. Breast cancer type 1 and neurodegeneration: consequences of deficient DNA repair.
    Leung E; Hazrati LN
    Brain Commun; 2021; 3(2):fcab117. PubMed ID: 34222870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The transrepression and transactivation roles of CtBPs in the pathogenesis of different diseases.
    Chen Z
    J Mol Med (Berl); 2021 Oct; 99(10):1335-1347. PubMed ID: 34196767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral Manipulation of the Host Epigenome as a Driver of Virus-Induced Oncogenesis.
    Soliman SHA; Orlacchio A; Verginelli F
    Microorganisms; 2021 May; 9(6):. PubMed ID: 34070716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma Metabolome Signature Indicative of
    Penkert J; Märtens A; Seifert M; Auber B; Derlin K; Hille-Betz U; Hörmann P; Klopp N; Prokein J; Schlicker L; Wacker F; Wallaschek H; Schlegelberger B; Hiller K; Ripperger T; Illig T
    Front Oncol; 2021; 11():627217. PubMed ID: 33898308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Class I histone deacetylase inhibition is synthetic lethal with BRCA1 deficiency in breast cancer cells.
    Zhang B; Lyu J; Yang EJ; Liu Y; Wu C; Pardeshi L; Tan K; Chen Q; Xu X; Deng CX; Shim JS
    Acta Pharm Sin B; 2020 Apr; 10(4):615-627. PubMed ID: 32322466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RARβ Agonist Drug (C286) Demonstrates Efficacy in a Pre-clinical Neuropathic Pain Model Restoring Multiple Pathways via DNA Repair Mechanisms.
    Goncalves MB; Moehlin J; Clarke E; Grist J; Hobbs C; Carr AM; Jack J; Mendoza-Parra MA; Corcoran JPT
    iScience; 2019 Oct; 20():554-566. PubMed ID: 31655065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic re-wiring of breast cancer by pharmacological targeting of C-terminal binding protein.
    Byun JS; Park S; Yi DI; Shin JH; Hernandez SG; Hewitt SM; Nicklaus MC; Peach ML; Guasch L; Tang B; Wakefield LM; Yan T; Caban A; Jones A; Kabbout M; Vohra N; Nápoles AM; Singhal S; Yancey R; De Siervi A; Gardner K
    Cell Death Dis; 2019 Sep; 10(10):689. PubMed ID: 31534138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of bidirectional gene pairs in The Cancer Genome Atlas (TCGA) dataset.
    Tu J; Li X; Wang J
    PeerJ; 2019; 7():e7107. PubMed ID: 31245179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.